AGP Executive Report
Last update: 6 hours agoCannabis regulation & enforcement: Thailand’s DTAM tightened enforcement for cannabis businesses breaching 2025 rules, with 30–90 day licence suspensions and possible revocation for repeat offences, including penalties for incomplete reporting and failure to meet cultivation/harvesting standards. Medical CBD trial update: Australia’s Avecho entered a trading halt ahead of interim results from its phase III synthetic CBD insomnia study (about 520 patients; 75mg or 150mg nightly vs placebo for 8 weeks), positioning CBD as a potential OTC pharmacy option. Hemp industry push: New Zealand’s Taranaki Hemp Hub released a hempcrete development plan, calling hempcrete the most immediate commercial pathway for locally grown and processed hemp fibre. Policy & public health ripple effects: Maine’s out-of-state-backed effort to roll back recreational cannabis legalization is back on the radar, while local cannabis supporters organize to oppose a potential 2027 ballot referendum. Healthcare tech & patient care: A report on “ambient intelligence” highlights how AI tools are being used to transcribe patient visits and automate parts of prescribing and charting—raising new questions for clinicians and health systems.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
